Compare International Business Machines Corp (IBM) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
International Business Machines Corp vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? International Business Machines Corp trades at $225.72 (market cap $207.75B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: International Business Machines Corp is far larger — about 3.6× Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.36%). Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 88 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| IBM | TAK | |
|---|---|---|
Market Cap | $207.75B | $58.16B |
Volume | 3,864,661 | 2,467,530 |
Sector | Technology | Health |
52-Week High | $329.23 | $19.05 |
52-Week Low | $205.77 | $13.23 |
Typical Hold Time | 88 Days | 0 Days |
Enterprise Value | $264.89B | $86.04B |
Dividend Yield | 3.07% | 3.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBM stock trades at $226.61, up 2.4% with recent momentum driven by positive sentiment in the consulting sector following Accenture's strong earnings. The company shows solid fundamentals with 2025 revenue growth to $67.54B and net income margin of 15.52%, though technical indicators remain bearish overall. Recent developments include the introduction of self-hosted deployment for IBM Bob AI platform and board expansion with Frank Baker's election.
IBM presents a mixed investment case with strong profitability metrics and analyst consensus target of $256.69 offering 13% upside, but faces headwinds from bearish technical signals and recent earnings miss. The company's pivot to high-margin hybrid cloud and AI consulting shows promise, though execution risks and competitive pressures in the AI space warrant caution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About International Business Machines Corp
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
